alcohol and nifurtimox: what the product label says
Read the product-label passage naming ethanol, with the source version, formulation and limitations.
The product label for sodium oxybate names ethanol in its drug-interaction information. The complete selected section is reproduced below so that qualifications stay with the finding.
sodium oxybate โ SOLUTION โ ORAL
Labeled active ingredients: SODIUM OXYBATE; 4-HYDROXYBUTANOIC ACID. Routes: ORAL. Dosage forms: SOLUTION.
Section: 7.1 Alcohol, Sedative Hypnotics, and CNS Depressants
Sodium oxybate oral solution is contraindicated for use in combination with alcohol or sedative hypnotics. Use of other CNS depressants may potentiate the CNS-depressant effects of sodium oxybate oral solution [see Warnings and Precautions (5.1)].
Read the full product label on DailyMed. Label version 3, dated 2026-04-21.
This passage applies to the labeled product and circumstances it describes. It must not be generalized to other routes or formulations. It does not independently validate CDIโs severity category, establish safety for an individual, or replace the full label. The stored interaction description and classification have not been changed by this article.
Automatic checks matched drug identities, retrieved and preserved the label, and checked the full quoted section with AI assistance on 2026-10-25. The public explanation uses a fixed template; model-written medical advice is not published. Independent clinical review has not been recorded.
Ask your pharmacist or prescriber whether the cited products, routes and circumstances apply to your medicines before changing treatment.
CDI checks every pair across up to 20 drugs โ backed by FDA and NIH data.
Drug interaction data sourced from U.S. FDA drug labeling via openFDA and the U.S. National Library of Medicine (NLM), National Institutes of Health. For informational purposes only. Always consult your pharmacist or physician before making any medication decisions.
Read the product-label passage naming ethanol, with the source version, formulation and limitations.
Read the product-label passage naming adefovir dipivoxil, with the source version, formulation and limitations.
Read the product-label passage naming methotrexate, with the source version, formulation and limitations.